BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 37035104)

  • 21. Trends and Age-Period-Cohort Effects on the Prevalence, Incidence and Mortality of Hepatocellular Carcinoma from 2008 to 2017 in Tianjin, China.
    Liu C; Wu J; Chang Z
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199687
    [No Abstract]   [Full Text] [Related]  

  • 22. Trends in Mortality Due to Malignant Neoplasms of Female Genital Organs in Poland in the Period 2000-2021-A Population-Based Study.
    Pikala M; BurzyƄska M
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in gynecological cancer incidence, mortality, and survival among elderly women: A SEER study.
    Priyadarshini S; Swain PK; Agarwal K; Jena D; Padhee S
    Aging Med (Milton); 2024 Apr; 7(2):179-188. PubMed ID: 38725691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980-2013): an analysis of population-based data in relation to socioeconomic changes.
    Banas T; Juszczyk G; Pitynski K; Nieweglowska D; Ludwin A; Czerw A
    Onco Targets Ther; 2016; 9():5521-30. PubMed ID: 27660470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal Cancer Incidence Trend and Projections in Tunisia (1994 - 2024).
    Khiari H; Ben Ayoub HW; Ben Khadhra H; Hsairi M
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2733-2739. PubMed ID: 29072401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring age-standardized cancer incidence rates and regional disparities: A retrospective cohort study of 8 major cancers in South Korea.
    Lee D; Yun HW; Kim N; Park J; Jung KW; Suh M; Shin DW
    Cancer Epidemiol; 2024 Jun; 91():102594. PubMed ID: 38870624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal Trends in the Incidence and Mortality of Major Reproductive-Related Cancers in Women in Guangzhou From 2010 to 2020: A Joinpoint and Age-Period-Cohort Study.
    Wang S; Liu S; Nie Z; Li Y; Li K; Liang H; Chen Q; Wen L; Xu H; Liang B; Qin P; Jing C
    Int J Public Health; 2023; 68():1605300. PubMed ID: 37035104
    [No Abstract]   [Full Text] [Related]  

  • 28. Time trends of major cancers incidence and mortality in Guangzhou, China 2004-2015: A Joinpoint and Age-Period-Cohort Analysis.
    Luo A; Dong H; Lin X; Liao Y; Liang B; Chen L; Lin G; Hao Y
    Cancer Med; 2021 Apr; 10(8):2865-2876. PubMed ID: 33724715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Trend and Prediction of Cervical Cancer Incidence in Delhi, India: An Age-Period-Cohort Analysis.
    Malhotra RK; Manoharan N; Deo SS
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2787-2795. PubMed ID: 36037135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.
    Wang L; Lu B; He M; Wang Y; Wang Z; Du L
    Front Public Health; 2022; 10():811044. PubMed ID: 35252092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term trends in the incidence of endometriosis in China from 1990 to 2019: a joinpoint and age-period-cohort analysis.
    Feng J; Zhang S; Chen J; Yang J; Zhu J
    Gynecol Endocrinol; 2021 Nov; 37(11):1041-1045. PubMed ID: 34519590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring temporal trends and influencing factors for thyroid cancer in Guangzhou, China: 2004-2018.
    Zhou J; Liang B; Liu Y; Wang S; Xu H; Li K; Liang H; Sun Z; Wang Y; Zhang J; Hu X; Qin P
    Endocrine; 2024 May; 84(2):509-523. PubMed ID: 37936008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer statistics, 2023.
    Siegel RL; Miller KD; Wagle NS; Jemal A
    CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-Based Temporal Trends and Ethnic Disparity in Cervical Cancer Mortality in South Africa (1999-2018): A Join Point and Age-Period-Cohort Regression Analyses.
    Olorunfemi G; Libhaber E; Ezechi OC; Musenge E
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551741
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.